Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahram Salek-Ardakani

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|June 18, 2026
Is Kaposi's sarcoma the end of the OX40/OX40L axis in atopic dermatitis?Shahram Salek-Ardakani
The Journal of Allergy and Clinical Immunology|April 14, 2009
Regulation of TH17 cells in the mucosal surfacesDaniel Mucida, Shahram Salek-Ardakani
Vaccine|September 24, 2005
Regulation of CD4 T cell memory by OX40 (CD134)Shahram Salek-Ardakani, Michael Croft
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 10, 2010
Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunityShahram Salek-Ardakani, Michael Croft
Immunological Reviews|October 25, 2011
OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory virusesJohn Goulding, Vikas Tahiliani, Shahram Salek-Ardakani
Nature Reviews. Drug Discovery|October 25, 2024
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancerMichael Croft, Shahram Salek-Ardakani, Carl F Ware
Journal for Immunotherapy of Cancer|February 27, 2021
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancerPaola Marie Marcovecchio, Graham Thomas, Shahram Salek-Ardakani
Virology|December 31, 2002
Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBVShahram Salek-Ardakani, John R Arrand, Mike Mackett
Frontiers in Immunology|September 4, 2023
Agonism of 4-1BB for immune therapy: a perspective on possibilities and complicationsShahram Salek-Ardakani, Dirk M Zajonc, Michael Croft
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alphaShahram Salek-Ardakani, Stephen A Lyons, John R Arrand
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|June 18, 2026
Is Kaposi's sarcoma the end of the OX40/OX40L axis in atopic dermatitis?Shahram Salek-Ardakani
The Journal of Allergy and Clinical Immunology|April 14, 2009
Regulation of TH17 cells in the mucosal surfacesDaniel Mucida, Shahram Salek-Ardakani
Vaccine|September 24, 2005
Regulation of CD4 T cell memory by OX40 (CD134)Shahram Salek-Ardakani, Michael Croft
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 10, 2010
Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunityShahram Salek-Ardakani, Michael Croft
Immunological Reviews|October 25, 2011
OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory virusesJohn Goulding, Vikas Tahiliani, Shahram Salek-Ardakani
Nature Reviews. Drug Discovery|October 25, 2024
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancerMichael Croft, Shahram Salek-Ardakani, Carl F Ware
Journal for Immunotherapy of Cancer|February 27, 2021
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancerPaola Marie Marcovecchio, Graham Thomas, Shahram Salek-Ardakani
Virology|December 31, 2002
Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBVShahram Salek-Ardakani, John R Arrand, Mike Mackett
Frontiers in Immunology|September 4, 2023
Agonism of 4-1BB for immune therapy: a perspective on possibilities and complicationsShahram Salek-Ardakani, Dirk M Zajonc, Michael Croft
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alphaShahram Salek-Ardakani, Stephen A Lyons, John R Arrand
Pageof 8